1. Home
  2. AVNT vs ARQT Comparison

AVNT vs ARQT Comparison

Compare AVNT & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avient Corporation

AVNT

Avient Corporation

N/A

Current Price

$43.01

Market Cap

4.1B

Sector

Industrials

ML Signal

N/A

Logo Arcutis Biotherapeutics Inc.

ARQT

Arcutis Biotherapeutics Inc.

N/A

Current Price

$26.57

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AVNT
ARQT
Founded
1927
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.1B
3.5B
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
AVNT
ARQT
Price
$43.01
$26.57
Analyst Decision
Buy
Buy
Analyst Count
8
8
Target Price
★ $53.13
$40.38
AVG Volume (30 Days)
651.6K
★ 2.0M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
★ 2.61%
N/A
EPS Growth
N/A
★ 88.79
EPS
★ 1.77
0.09
Revenue
★ $3,835,500,000.00
$376,072,000.00
Revenue This Year
$6.78
$44.19
Revenue Next Year
$4.02
$29.31
P/E Ratio
★ $24.48
$302.33
Revenue Growth
1.71
★ 91.34
52 Week Low
$28.50
$19.30
52 Week High
$49.08
$34.80

Technical Indicators

Market Signals
Indicator
AVNT
ARQT
Relative Strength Index (RSI) 47.34 41.77
Support Level $35.57 $25.08
Resistance Level $46.11 $28.67
Average True Range (ATR) 1.42 1.59
MACD -0.34 -0.35
Stochastic Oscillator 2.67 12.64

Price Performance

Historical Comparison
AVNT
ARQT

About AVNT Avient Corporation

Avient Corp manufactures and sells various chemical and plastic-based products to designers and plastic processors. The firm operates in two reportable segments: Color, Additives and Inks, and Specialty Engineered Materials. The company's product portfolio includes concentrated color and ink blends, plastic resins, and various specialized polymer materials used in industries such as food packaging, construction, transportation, cosmetics, and healthcare. The Color, Additives, and Inks segment and the distribution segment generate maximum revenue. Geographically, the company generates maximum revenue from the United States and Canada, followed by EMEA, Asia, and Latin America.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Share on Social Networks: